Phoenix Holdings Ltd. purchased a new stake in Livongo Health, Inc. (NASDAQ:LVGO) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,707 shares of the company’s stock, valued at approximately $223,000.
Several other hedge funds have also added to or reduced their stakes in the company. Patriot Financial Group Insurance Agency LLC boosted its position in Livongo Health by 106.4% during the third quarter. Patriot Financial Group Insurance Agency LLC now owns 194 shares of the company’s stock worth $27,000 after acquiring an additional 100 shares during the last quarter. PrairieView Partners LLC acquired a new stake in Livongo Health during the third quarter worth approximately $28,000. Capital Advisors Ltd. LLC acquired a new stake in Livongo Health during the third quarter worth approximately $30,000. FNY Investment Advisers LLC acquired a new stake in Livongo Health during the third quarter worth approximately $33,000. Finally, Prospera Financial Services Inc acquired a new stake in Livongo Health during the third quarter worth approximately $37,000. Institutional investors and hedge funds own 41.67% of the company’s stock.
NASDAQ LVGO opened at $139.77 on Friday. Livongo Health, Inc. has a one year low of $18.76 and a one year high of $151.05. The company has a 50-day simple moving average of $140.76 and a 200-day simple moving average of $108.40. The company has a debt-to-equity ratio of 0.69, a quick ratio of 19.51 and a current ratio of 19.88. The firm has a market capitalization of $14.20 billion, a PE ratio of -349.42 and a beta of 1.81.
Livongo Health (NASDAQ:LVGO) last posted its quarterly earnings results on Wednesday, October 28th. The company reported $0.16 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.05 by $0.11. Livongo Health had a negative net margin of 12.20% and a positive return on equity of 0.29%. Equities analysts forecast that Livongo Health, Inc. will post -0.06 earnings per share for the current year.
The firm also recently declared a dividend, which was paid on Tuesday, November 3rd. Stockholders of record on Thursday, October 29th were issued a $7.09 dividend. The ex-dividend date of this dividend was Monday, November 2nd.
A number of analysts recently issued reports on the stock. Citigroup raised their target price on shares of Livongo Health from $125.00 to $170.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. KeyCorp lifted their price target on shares of Livongo Health from $153.00 to $156.00 and gave the stock an “overweight” rating in a research note on Thursday, October 29th. Canaccord Genuity lifted their price target on shares of Livongo Health from $110.00 to $139.00 and gave the stock a “buy” rating in a research note on Monday, August 17th. Piper Sandler downgraded shares of Livongo Health from an “overweight” rating to a “neutral” rating and lifted their price target for the stock from $55.00 to $143.00 in a research note on Wednesday, October 28th. Finally, BidaskClub downgraded shares of Livongo Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 13th. Eight investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Livongo Health presently has an average rating of “Buy” and an average price target of $106.29.
In other Livongo Health news, Director Karen L. Daniel sold 15,000 shares of the business’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $126.71, for a total transaction of $1,900,650.00. Following the completion of the transaction, the director now directly owns 64,142 shares of the company’s stock, valued at approximately $8,127,432.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider James Pursley sold 738 shares of the business’s stock in a transaction dated Wednesday, August 26th. The shares were sold at an average price of $132.53, for a total transaction of $97,807.14. Following the transaction, the insider now directly owns 73,294 shares of the company’s stock, valued at $9,713,653.82. The disclosure for this sale can be found here. Insiders sold a total of 691,865 shares of company stock valued at $86,180,389 over the last ninety days. Company insiders own 13.00% of the company’s stock.
Livongo Health Profile
Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.
Read More: G-20
Want to see what other hedge funds are holding LVGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Livongo Health, Inc. (NASDAQ:LVGO).
Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.